OQROGet OQRO Pro
Insider trade

Pulse Biosciences (PLSE)Director sold ~$407K

Darrin Uecker, Director at Pulse Biosciences, sold ~$407K of Pulse Biosciences shares.

~$407K
Approx. value · 25K sh @ $16.28
123K
Holds after · shares reported
Traded
Sep 16, 2025
Filed
Sep 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 11, 2024InsiderDirector purchased ~$189K of PLSE shares in the open market
  2. Sep 12, 2024InsiderDirector purchased ~$2.09M of PLSE shares in the open market
  3. Sep 10, 2025InsiderDirector purchased ~$508K of PLSE shares in the open market
  4. Sep 11, 2025InsiderDirector sold ~$370K of PLSE shares in the open market
  5. Sep 12, 2025InsiderDirector sold ~$358K of PLSE shares in the open market
  6. Sep 15, 2025InsiderDirector sold ~$394K of PLSE shares in the open market
  7. Sep 16, 2025 · this disclosureInsiderDirector sold ~$407K of PLSE shares in the open market

What came next

  1. Sep 17, 2025InsiderDirector sold ~$324K of PLSE shares in the open market
  2. Sep 18, 2025InsiderOfficer sold ~$370K of PLSE shares in the open market
  3. Sep 19, 2025InsiderOfficer sold ~$7.4K of PLSE shares in the open market
  4. Nov 5, 2025Company filing · Form 8-K · ResultsReported its results
  5. Jan 8, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 8, 2026, the Board of Directors (the “Board”) of Pulse Biosciences, Inc. (the “Company”) elected Maria Sainz to the Board, effective immediately. Ms. Sainz will serve until her term expires at the annual meeting of stockholders to be held in 2026 and until her successor is elected and qualified or until her earlier death, resignation or removal.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Pulse Biosciences

OQRO holds no insider, Congress, fund or contract record for Pulse Biosciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PLSE page.

Other recent filings by Darrin Uecker, Chief Technology Officer

The full history of Darrin Uecker, Chief Technology Officer is on the profile page.

How this filing works

Other disclosures at Pulse Biosciences

Everything OQRO holds on this company is on its PLSE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data